NCT04719247 (RCT) is a NA clinical trial of Pulpotomy in Pulpitis - Irreversible, sponsored by Ain Shams University.

Who is sponsoring NCT04719247?

NCT04719247 is sponsored by Ain Shams University.

What drugs are being tested in NCT04719247?

Interventions in NCT04719247: Pulpotomy.

What condition does NCT04719247 study?

NCT04719247 studies Pulpitis - Irreversible.

Is NCT04719247 still recruiting?

NCT04719247 is currently completed. Last updated 15 December 2021.

Last reviewed 2021-12-15 · How we verify

NCT04719247: RCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical and Radiographic Evaluation of Turmeric, Thymus Vulgaris, Nigella Sativa and Aloe Vera as Pulpotomy Medicaments in Primary Teeth

Completed NA Last updated 15 December 2021

What this trial tests

NA trial testing Pulpotomy in Pulpitis - Irreversible in 90 participants. Completed in 1 November 2021.

Timeline

1 November 2019

Primary endpoint
1 May 2021

1 November 2021

Quick facts

Lead sponsor	Ain Shams University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	90
Start date	1 November 2019
Primary completion	1 May 2021
Estimated completion	1 November 2021
Sites	1 location across Egypt

Drugs / interventions tested

Pulpotomy

Conditions studied

Pulpitis - Irreversible — all drugs for Pulpitis - Irreversible →

Sponsor

Ain Shams University

Who can join

Adults 4 to 7, any sex, with Pulpitis - Irreversible. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

when caries reaches the pulp of the tooth, it has to be removed and replaced with a material. In this study im examining the clinical and radiographic signs and symptoms after using different natural materials in pulpotomized molars and compared to the formocresol.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical and Radiographic Evaluation of <i>Nigella sativa</i> and <i>Aloe vera</i> as Pulpotomy Medicaments in Primary Teeth: A Randomized Controlled Trial.
Sharaf RM, Kabil NS, Youssef FS, Awad BG. · · 2023 · cited 3× · PMID 38078020 · DOI 10.5005/jp-journals-10005-2657

Verify or expand the search:

Other trials of Pulpotomy

Trials testing the same drug.

NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
NCT06293521 — Clinical and Radiographic Success Rate of Pulpotomy Versus Pulpectomy for Management of Primary Teeth With Deep Caries · Phase 2 · recruiting
NCT07230717 — Evaluation of Pulpotomy Versus Pulpectomy in Primary Molars With Irreversible Pulpitis or Necrotic Pulp · NA · not yet recruiting
NCT07171229 — Evaluation of Cytokines Level as an Indicator of Pulp Inflammation and Its Relation to the Success Rates of Pulpotomy in · NA · not yet recruiting
NCT06904781 — Treatment Outcomes of Pulpotomy Versus Pulpectomy in Vital Primary Molars Diagnosed With Irreversible Pulpitis · NA · not yet recruiting

Other recruiting trials for Pulpitis - Irreversible

Currently open trials in the same condition.

NCT07245004 — Effect of Cryotherapy on Postoperative Pain for Pulpotomy · EARLY_PHASE1 · active not recruiting
NCT07340606 — The Role of the Pre-operative Condition and Artificial Intelligence-Assisted Diagnosis in Predicting the Success of Full · NA · recruiting
NCT07375576 — Outcomes of Pulpotomy and Root Canal Treatment in Teeth With Symptomatic Irreversible Pulpitis · NA · recruiting
NCT07306533 — Effect of Menstrual Phase on the Anesthetic Efficacy · NA · recruiting
NCT07130214 — The Effect of Genetic Polymorphisms on the Success of Vital Pulp Therapy · active not recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04719247 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 15 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04719247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing